Literature DB >> 26054968

Assessment of the Validity and Reproducibility of the Pap Smear in Mexico: Necessity of a Paradigm Shift.

Elsa Yunes-Díaz1, Patricia Alonso-de Ruiz1, Eduardo Lazcano-Ponce2.   

Abstract

BACKGROUND AND AIMS: An assessment was performed of the quality of Pap readings in 19 cytology laboratories (CLs) in Mexico from the Cervical Cancer Screening Program.
METHODS: Nine CLs were affiliated with the Health Ministry (SSA), and ten were affiliated with the Mexican Social Security Institute (IMSS). Two sets of 200 cervical cytology specimens were prepared, one set for each institution. Fourteen percent of the specimens were positive and six were inappropriate for diagnosis (3%). All cervical cytology specimens were processed in the cytopathology laboratory at the General Hospital of Mexico, and histopathology was available for each positive case.
RESULTS: Thirty percent of the SSA reading centers had a sensitivity of at least 80%; however, not one of the ten IMSS laboratories evaluated reached this figure. Some reading centers had a sensitivity <65%, meaning that nearly half of the specimens with a cytology consistent with cervical neoplasm were not identified. DISCUSSION: Given these results, it is a priority to effect a paradigm shift combining various screening tests to improve adherence to standards and enhanced cost-effectiveness of the early detection of cervicouterine cancer (CC) in Mexico.
Copyright © 2015 IMSS. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cervical cytology; Cervicouterine cancer; Pap smear

Mesh:

Year:  2015        PMID: 26054968     DOI: 10.1016/j.arcmed.2015.05.013

Source DB:  PubMed          Journal:  Arch Med Res        ISSN: 0188-4409            Impact factor:   2.235


  2 in total

1.  Diagnostic Role of Papanicolaou Smear, Hemoglobin, Blood Group, and Other Clinical Symptoms in Detecting Endometrial Carcinoma: A Clinicopathological Study of 175 Iranian Women with Endometrial Carcinoma.

Authors:  Maryam Sadat Hosseini; Shima Mohammadian; Farah Farzaneh; Maliheh Arab; Tahereh Ashrafganjoei
Journal:  Gynecol Minim Invasive Ther       Date:  2020-08-01

2.  Serum Levels of Galectin-9 are Increased in Cervical Cancer Patients and are Higher in Advanced Clinical Stages.

Authors:  Tania Reyes-Vallejo; Ileana Conde-Rodríguez; Jocelyn Serna-Villalobos; Ivonne Ramírez-Díaz; Gabriela Pérez-Villalobos; Guadalupe Delgado-López; Víctor Javier Vazquez-Zamora; Claudia Teresita Gutiérrez-Quiroz; Laura Ávila-Jiménez; Alejandro García-Carrancá; Liliana Martínez-Acosta; Gerardo Santos-López; Julio Reyes-Leyva; Verónica Vallejo-Ruiz
Journal:  Onco Targets Ther       Date:  2022-10-13       Impact factor: 4.345

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.